The research studies are testing low-intensity focused ultrasound neuromodulation for treating tobacco use disorder, opiate use disorder, and chronic pain.
Because they are taking place at the Washington DC VA Medical Center, enrollment is only open to veterans.
Dr. Lee is a physician-scientist who specializes in addiction medicine at the US Department of Veterans Affairs (VA) Washington DC VA Medical Center.
Learn more about her laboratory and why she’s passionate about finding non-pharmaceutical treatments for addiction and chronic pain to benefit the veteran population.
HistoSonics’ recent landmark acquisition positioned the company as the North Star in the field of focused ultrasound.
In this blog, Foundation Chairman Neal Kassell, MD, addresses how early government funding was critical to the company’s success and how funding cuts could hinder future medical innovation.
The European Medicines Agency (EMA) expert panel advice for Orphan Medical Device status will support clinical development strategy and clarify steps for Carthera’s CE marking application.
This European Union pilot program was launched in 2024 to support early access pathways for innovative devices targeting rare diseases.
The DIPG/DMG Research Funding Alliance grants support research, trial access, and data use projects that move the needle in pediatric brain tumor discoveries.
“Walking is better, and my voice used to be really hoarse, but it's not any longer. I see slow, gradual improvements. But I exercise a lot...I'm not somebody that likes to sit around. I have to go, go, go.”
‒ Bill, ALS patient on life after focused ultrasound